Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Dietary fish oil containing omega 3 highly unsaturated fatty acids has cardioprotective and anti-inflammatory effects. Prostaglandins (PGs) and thromboxanes are produced in vivo both from the omega 6 fatty acid arachidonic acid (AA) and the omega 3 fatty acid eicosapentaenoic acid (EPA). Certain beneficial effects of fish oil may result from altered PG metabolism resulting from increases in the EPA/AA ratios of precursor phospholipids. Here we report in vitro specificities of prostanoid enzymes and receptors toward EPA-derived, 3-series versus AA-derived, 2-series prostanoid substrates and products. The largest difference was seen with PG endoperoxide H synthase (PGHS)-1. Under optimal conditions purified PGHS-1 oxygenates EPA with only 10% of the efficiency of AA, and EPA significantly inhibits AA oxygenation by PGHS-1. Two- to 3-fold higher activities or potencies with 2-series versus 3-series compounds were observed with PGHS-2, PGD synthases, microsomal PGE synthase-1 and EP1, EP2, EP3, and FP receptors. Our most surprising observation was that AA oxygenation by PGHS-2 is only modestly inhibited by EPA (i.e. PGHS-2 exhibits a marked preference for AA when EPA and AA are tested together). Also unexpectedly, TxA(3) is about equipotent to TxA(2) at the TP alpha receptor. Our biochemical data predict that increasing phospholipid EPA/AA ratios in cells would dampen prostanoid signaling with the largest effects being on PGHS-1 pathways involving PGD, PGE, and PGF. Production of 2-series prostanoids from AA by PGHS-2 would be expected to decrease in proportion to the compensatory decrease in the AA content of phospholipids that would result from increased incorporation of omega 3 fatty acids such as EPA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“EPA derived eicosanoids also display a reduced affinity for eicosanoid receptors rendering them up to 50%–80% less biologically active than AA derived eicosanoids [149].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [149]
In the citing paper
“Conversely, eicosanoids derived from n-3 PUFAs are considered to be less potent, reducing the intensity and duration of the inflammatory responses by immune cells [62].”
From Potential Roles of n-3 PUFAs during Skeletal Muscle Growth and Regeneration (2018) · cites this paper as [62]
Citations
Cites
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Self-citationThe Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Diversity of group types, regulation, and function of phospholipase A2.
Dennis, E. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36794-7 · Cited by 1,436
Biochemistry of Lipids, Lipoproteins and Membranes
(2021) · Elsevier eBooks · doi:10.1016/c2020-0-00089-7 · Cited by 1,400
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Self-citationSugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
Research works printed but not linked: 4
- Kris-Etherton, 2003, Arterioscler. Thromb. Vasc. Biol., 23, 20
- Fisher, 1989, Mol. Pharmacol., 35, 195
- Lands, 1973, Adv. Biosci., 9, 15
- Yu, 2005, J. Clin. Invest., 115, 986, 10.1172/JCI23683 · doi:10.1172/jci23683 · Paper page
Cited by
Items 401–404 of 404
Aslan, C., Kaplan, O., Yalçın, N., Fidan, B. B., Çelebier, M., Ünal, D., & Allegaert, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156995
“First, prostaglandin E3 (PGE3), the principal cyclooxygenase product of eicosapentaenoic acid (EPA), attenuates COX-2 gene expression and limits interleukin-6 secretion [10], while opposing PGE2 signaling through differential receptor engagement [11].”
Egalini, F., Riccio, E., Grasso, M., Nelva, A., & Geronimo, V. D. (2026) · Nutrients · doi:10.3390/nu18152538
“For instance, prostaglandin E3 (PGE3) has been shown to exhibit 50–80% lower potency compared to PGE2 at various receptor subtypes [32].”
Airway inflammation and omega 3 PUFA in mild to moderate asthma
Kumar, A. P. R. (2013) · Loughborough University Institutional Repository (Loughborough University)
Metadata
- Authors
- Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., Smyth, E. M., Wilson, S. J., FitzGerald, G. A., Garavito, R. M., Sui, D. X., Regan, J. W., & Smith, W. L.
- Affiliations
- University of Michigan (US)
- Tokyo Medical and Dental University (JP)
- University of Pennsylvania (US)
- Michigan State University (US)
- University of Arizona (US)
- Corresponding author
- Smith, William L.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 31
- Pages
- 22254-22266
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047319374
- Cited by
- 400
- References
- 121
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 14 · 2021: 21 · 2020: 25 · 2019: 22 · 2018: 24 · 2017: 26 · 2016: 24 · 2015: 26 · 2014: 32 · 2013: 28 · 2012: 22
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32hl075993-01a1)
- National Heart, Lung, and Blood Institute (HL075993, HL56773, R01HL056773)
- National Institute of General Medical Sciences (GM-68848, R01GM068848)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- prostaglandins, eicosapentaenoic acid, arachidonic acid, omega-3 fatty acids, fish oil, prostanoid metabolism, cyclooxygenase-1, cyclooxygenase-2, prostaglandin D synthase, prostaglandin E receptors, prostaglandin F receptor, substrate specificity, EPA/AA ratio, phospholipid fatty acid composition
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Line, Fish Oils, Humans, Inositol Phosphates, Phospholipids, Prostaglandins, Thromboxane A2, Thromboxanes, Eicosapentaenoic Acid, Signal Transduction, Arachidonic Acid, Mice, Platelet-Rich Plasma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.